SSC 16 - SSC Session -  Working Group on Hemostatic Management of Liver Disease

Presentations:

• 4:30 PM – 4:35 PM

  Introduction
  

  Speaker: Ton Lisman, PhD (he/him/his) – UMCG

  Speaker: Pierre-Emmanuel Morange, MD, PhD – Aix-Marseille Univ, INSERM, INRAE, C2VN, Laboratory of Haematology, Hôpitaux de Marseille, Marseille, France
• 4:35 PM – 4:50 PM

  Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis
  

  Speaker: Fanny Turon, MD, PhD – Hospital Clinic Barcelona
• 4:50 PM – 5:05 PM

  Prevention of Recurrence of Cirrhotic Portal Vein Thrombosis
  

  Speaker: Aurelie Plessier, MD – Université de Paris, Centre de recherche sur l'inflammation, Inserm
• 5:05 PM – 5:15 PM

  Difficulties in Monitoring Anticoagulant Therapy in Patients With Cirrhosis
  

  Speaker: Ton Lisman, PhD (he/him/his) – UMCG
• 5:15 PM – 5:35 PM

  Q&A
  

  Speaker: Maria Magnusson, MD, PhD – Karolinska Institute
• 5:35 PM – 5:50 PM

  Procedural Related Bleeding in Patients With Liver Disease Update (PROC-Bleed)
  

  Speaker: Nicolas Intagliata, MD – University of Virginia
• 5:50 PM – 6:10 PM

  Prevention of Bleeding in Patients With Cirrhosis - What Do Guidance Documents Tell Us
  

  Speaker: Lara N. Roberts, MD – King's College Hospital NHS Foundation Trust
• 6:10 PM – 6:25 PM

  Q&A
  

  Speaker: Simon J. Stanworth, DPhil FRCP FRCPath – Oxford University Hospitals/NHS Blood and Transplant
• 6:25 PM – 6:30 PM

  Conclusion
  

  Speaker: Ton Lisman, PhD (he/him/his) – UMCG